Liverpool, United Kingdom

Declan Greally

This inventor holds 1 USPTO granted patent. Top assignee: Medeva Europe Limited. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Declan Greally. Retrieved from https://idiyas.com/inventor/declan-greally

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Declan Greally: Innovator in Vaccine Preservation

Introduction

Declan Greally is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of vaccine preservation, particularly through his innovative methods aimed at enhancing the safety and efficacy of vaccines.

Latest Patents

Declan holds a patent for a "Method of preservation of vaccines with polybiguanide." This method is designed to prevent or reduce bacterial contamination of viral vaccines. It involves adding an effective preserving amount of a polybiguanide-containing preservative composition to a solution containing vaccine virus or virus antigen. This technique is especially beneficial in the manufacturing process of influenza vaccines, ensuring higher safety standards.

Career Highlights

Declan Greally is currently employed at Medeva Europe Limited, where he continues to work on advancements in vaccine technology. His expertise in this area has positioned him as a valuable asset to his company and the broader scientific community.

Collaborations

Declan collaborates with various professionals in the field, including his coworker, Michelle Irene Gregarach Lawrence. Their combined efforts contribute to the ongoing development of innovative solutions in vaccine preservation.

Conclusion

Declan Greally's work in vaccine preservation exemplifies the importance of innovation in healthcare. His patented method not only enhances the safety of vaccines but also reflects his commitment to improving public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…